XTL Biopharmaceuticals Files Application for Listing on the NASDAQ – Sacramento Bee
XTL Biopharmaceuticals Files Application for Listing on the NASDAQ Sacramento Bee By XTL Biopharmaceuticals Ltd XTL Biopharmaceuticals Ltd. (TASE: XTL) (OTC: XTLBY) (the "Company"), a biopharmaceutical development company, announced today that it has filed an application for relisting its ADRs on the NASDAQ Stock Exchange.